FIELD: chemistry.
SUBSTANCE: present invention pertains to a compound with general formula 
where R' stands for phenyl, unsubstituted or substituted with one or more substitutes, chosen from a group comprising alkyl, alkoxy group, halogen, -(CH2)oOH, -C(O)H, CF3, CN, S-alkyl, -S(O)1,2-alkyl, -C(O)NR'R", -NR'R"; R2 and R3 independently stand for hydrogen, halogen, alkyl, alkoxy group, OCHF2, OCH2F, OCF3 or CF3 and R4 and R5 independently stand for hydrogen, -(CH2)2SCH3, -(CH2)2S(O)2CH3, -(CH2)2S(O)2NHCH3, -(CH2)2NH2, -(CH2)2NHS(O)2CH3 or -(CH2)2NHC(O)CH3, R' stands for hydrogen, alkyl, -(CH2)oOH, -S(O)2- alkyl, -S(O)-alkyl, -S-alkyl; R" stands for hydrogen or alkyl; o stands for 0, 1, 2 or 3. The invention also relates to use of formula I compounds in making medicinal preparations for treating schizophrenia, for treating positive and negative symptoms of schizophrenia and medicine for treating schizophrenia.
EFFECT: obtaining new compounds with useful biological properties.
55 cl, 421 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF RECEPTOR NK-1 ANTAGONISTS FOR TREATING CRANIOCEREBRAL AND SPINAL TRAUMAS OR NERVOUS TISSUE LESION | 2002 |
|
RU2304435C2 |
| DERIVATIVES OF 4-PHENYLPYRIDINE AND MEDICINAL AGENT BASED ON THEREOF | 2001 |
|
RU2277087C2 |
| DERIVATIVES OF 3-PHENYLPYRIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2236402C2 |
| DOUBLE NEUROKININ-1/NEUROKININ-3 RECEPTOR ANTAGONISTS FOR TREATING SEX HORMONE DEPENDENT DISEASES | 2016 |
|
RU2743206C2 |
| DERIVATIVES OF 4-PHENYLPYRIDINE AND MEDICINAL AGENT | 2001 |
|
RU2276139C2 |
| N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER | 2005 |
|
RU2427572C2 |
| DERIVATIVES OF 5-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244710C2 |
| DERIVATIVES OF 4-PHENYLPYRIDINE N-OXIDES, MEDICINAL AGENT COMPRISING THEREOF | 2001 |
|
RU2266284C2 |
| DERIVATIVES OF 4-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2243221C2 |
| HYDROXYLATED AND METHOXYLATED CYCLOPENTA[B]PYRIMIDINES AS PROTEIN KINASE INHIBITORS | 2007 |
|
RU2478632C2 |
